Search Videos and More
News
Expanding the Role and Responsibilities of Urologic Advanced Practice Providers
Since 2024, the Fox Chase – Temple Urologic Institute has grown exponentially, increasing demand for highly trained advanced practice providers (APPs) to work alongside attending specialists. Recently, eight new APPs have joined the team to address the expanding clinical needs in both urologic oncology and general urology, with clinic appointments often exceeding capacity.
News
Two New Carol and Louis Della Penna Chairs at Fox Chase
Carol and Louis Della Penna are two of Fox Chase Cancer Center’s most generous and committed supporters. Recently, two esteemed urologists received the honor of an endowed chair:
News
Preserving Life and Quality of Life in Muscle-Invasive Bladder Cancer
Fox Chase-developed RETAIN clinical trials explore bladder preservation for selected patients
News
U.S. News & World Report Recognizes Fox Chase Cancer Center Among Nation’s Best Hospitals for Cancer Care
U.S. News & World Report has ranked Fox Chase Cancer Center among the nation’s top hospitals for cancer care according to the publication’s 2026-27 Best Hospitals rankings.
News
Doximity Ask AI May Be Smart, but Trusted Answers Still Depend on Physicians Like Dr. Cohn
A longtime Doximity user, Joshua Cohn, MD, FPMRS, Associate Professor, Department of Urology, Fox Chase Cancer Center and Fox Chase – Temple Urologic Institute provider, had relied on the company’s dialer service for years.
News
Transforming Urologic Care in Philadelphia and Worldwide. The Fox Chase – Temple Urologic Institute.
In just four years, the Fox Chase – Temple Urologic Institute has leveraged the expertise of two renowned institutions to deliver an exceptionally broad range of aligned and specialized urology and urologic oncology services, led by eminent clinicians and thought leaders.
News
Fox Chase – Temple Urologic Institute at AUA 2026
Visit the Fox Chase-Temple Urologic Institute Booth #2464 in the Science & Technology Hall.
News
Preparing for the Routine and Unforeseen in the Urologic OR
From 11 am to 11 pm, Joon Park, MSHI, BSN, RN, CNOR, Fox Chase Cancer Center Perioperative Evening Charge Nurse, manages the surgical staff workflow and patient assignments for the Fox Chase Cancer operating room.
News
Fox Chase Cancer Center Researcher Secures Funding to Investigate Toxicity Reduction in Bladder Cancer Treatment
Pooja Ghatalia, MD, Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, developed a trial to administer therapy for metastatic urothelial carcinoma patients in a new way. The Department of Defense awarded Ghatalia a $1.9 million grant to pursue the research, making it one of only five chosen out of 51 studies.
Video
Complex Patient Case Review for Oncologic and Benign Urology
The Fox Chase–Temple Urologic Institute delivers expert care for both complex oncologic and benign urologic conditions. Backed by a team of renowned urologic specialists, we are recognized regionally and internationally for offering innovative, leading-edge treatments.
News
New Fox Chase Cancer Center Study Shows Partially Absorbable Mesh Significantly Lowers Parastomal Hernia Risk Following Bladder Removal
Parastomal hernia is a common complication among patients who undergo bladder removal and ileal conduit urinary diversion. Now, a new study “Very Low Rate of Parastomal Hernia Using Partially Absorbable Macroporous Mesh for Prophylactic Reinforcement in Ileal Conduit Urinary Diversion: A Collaborative Approach Between Urology and Plastic/Reconstructive Surgery,” presented by Fox Chase Cancer Center clinicians at the American Urological Association’s (AUA) 2025 Annual Meeting supports the use of partially absorbable synthetic, non-biologic parastomal mesh to significantly reduce this risk in real-world practice.
News
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.